Gain Therapeutics, Inc.GANXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank71
3Y CAGR-15.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-15.4%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$4.99M-
2024$0.00-
2023$0.00-100.0%
2022$8.24M+15.1%
2021$7.16M-
2020$0.00-
2019$0.00-
2018$0.00-